Crossmark

Development and Optimization of Candesartan Cilexitil-Loaded Ethosomal Gel for Enhanced Delivery: Improving Transdermal Therapeutics Via Box‒Behnken Statistical Design

Crossref DOI link: https://doi.org/10.1007/s12247-025-10342-8

Published Online: 2026-01-16

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sharma, Abhishek

Modgil, Mridul

Saeedan, Abdulaziz S.

Aldossary, Sara A

Kabra, Atul
License Information

Text and Data Mining valid from 2026-01-16

Version of Record valid from 2026-01-16
More Information

Article History

Received: 28 October 2025

Accepted: 21 December 2025

First Online: 16 January 2026

Competing Interests

: The authors declare no competing interests.

: The authors reported having no potential conflicts of interest.

Document is current

Any future updates will be listed below